Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

TAVR still a safe treatment option for immunocompromised patients
While patients with a weakened immune system are still more likely to die after TAVR than other patients, those deaths are largely not related to the procedure or any other cardiovascular issues. This new meta-analysis explored data from a variety of clinical trials.
Pope welcomes cardiologists to Vatican City
Pope Leo XIV told interventional cardiologists their work “stands at the crossroads of science, compassion and ethical responsibility.” When they treat patients, he added, they are treating the heart “both physically and metaphorically, bringing relief to those who suffer.”
Edwards Lifesciences shares positive outlook for 2026, pointing to continued importance of TAVR
The company expects TAVR sales alone to be as high as $4.9 billion in 2026. Other minimally invasive therapies are projected to make a major impact as well.
FDA commissioner claims Biden administration hid heart risks of COVID-19 vaccines from public
The allegation came days after an internal FDA memo linked the vaccines to the deaths of multiple children. A group of former FDA commissioners pushed back against the content of that memo.
Community Health Systems sells ambulatory diagnostics segment to Labcorp for $194M
The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business.

Homegrown tracking boosts follow-up imaging for incidental findings of uncertain gravity

A structured program to track incidental findings on body CT has significantly boosted rates of clinician follow-up as well as timely patient adherence to radiologist recommendations for next exams.

A CT coronary calcium scoring exam at Northwestern Medicine's Central DuPage Hospital in the Chicago Suburbs. Dave Fornell

The remaining gaps in evidence for cardiac CT

While the ACC/AHA 2021 Chest Pain Assessment Guidelines included cardiac CT angiography as a top level recommendation, gaps in evidence still need to be filled.

FDA calls out weight loss pills for ‘hidden’ ingredient that puts health of heart patients at risk

The agency’s own analysis confirmed that these capsules contain sibutramine, which was removed from the market back in 2010 due to safety concerns

HHS issues guidance as COVID-19 PHE winds down

The guidance clarifies what will and will not be impacted by the sunset of the PHE on May 11.

a 3D intracardiac echo (ICE) view of a surgical mitral valve using the GE NuVision ICE system.

Can intracardiac echo replace TEE during structural heart procedures?

TEE has been used to guide most transcatheter structural heart cases over the past decade, but 3D ICE is changing how some centers image those patients.

Healthcare consumers are coming up to speed on IR, albeit too slowly for some insiders

In the years since the turn of the century, interventional radiology has made quantifiable strides toward familiarizing the general public with the specialty and, along the way, helping IR better compete for business with surgery.

A busy week for cardiology investments: 3 tech companies report big financing rounds

It’s not even Valentine’s Day yet, but February has already been a big month for fundraising in the cardiology space.

Abbott to acquire vascular disease specialists for $890M

Minnesota-based Cardiovascular Systems Inc. is perhaps best known for its atherectomy devices designed to treat PAD and CAD.

Clinical

TAVR still a safe treatment option for immunocompromised patients

Pope welcomes cardiologists to Vatican City

Edwards Lifesciences shares positive outlook for 2026, pointing to continued importance of TAVR

FDA commissioner claims Biden administration hid heart risks of COVID-19 vaccines from public

Community Health Systems sells ambulatory diagnostics segment to Labcorp for $194M